Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression

被引：0
|
作者：
Park, H-Y. [1 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Pulm Internal Med, Hwasun, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 04期
关键词：
D O I：
10.1016/S1556-0864(18)30325-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48P
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [31] Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients
    Kumar, Sachin
    Pandey, Monu
    Mir, Ishfaq A.
    Mukhopadhyay, Abhirup
    Sharawat, Surender K.
    Jain, Deepali
    Saikia, Jyoutishman
    Malik, Prabhat S.
    Kumar, Sunil
    Mohan, Anant
    HUMAN CELL, 2022, 35 (01) : 286 - 298
  • [32] Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients
    Sachin Kumar
    Monu Pandey
    Ishfaq A. Mir
    Abhirup Mukhopadhyay
    Surender K. Sharawat
    Deepali Jain
    Jyoutishman Saikia
    Prabhat S. Malik
    Sunil Kumar
    Anant Mohan
    Human Cell, 2022, 35 : 286 - 298
  • [33] Expression of Programmed Death-Ligand 1 and Programmed Death-1 in Patients with Extramammary Paget's Disease
    Goto, Hiroyuki
    Sugita, Kazunari
    Yamamoto, Osamu
    INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (02) : 169 - 173
  • [34] Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer In what state is this art?
    Kerr, Keith M.
    Tsao, Ming-Sound
    Nicholson, Andrew G.
    Yatabe, Yasushi
    Wistuba, Ignacio I.
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (07) : 985 - 989
  • [35] Significance of programmed death-ligand 1 expression in resected lung cancer and its relationship with EGFR mutation
    Osoegawa, Atsushi
    Abe, Miyuki
    Takumi, Yohei
    Hashimoto, Takafumi
    Karashima, Takashi
    Miyawaki, Michiyo
    Sugio, Kenji
    THORACIC CANCER, 2023, 14 (24) : 2467 - 2472
  • [36] Prognostic value of programmed death-ligand 1 expression in patients with stage III colorectal cancer
    Koganemaru, Shigehiro
    Inoshita, Naoko
    Miura, Yuji
    Miyama, Yu
    Fukui, Yudai
    Ozaki, Yukinori
    Tomizawa, Kenji
    Hanaoka, Yutaka
    Toda, Shigeo
    Suyama, Koichi
    Tanabe, Yuko
    Moriyama, Jin
    Fujii, Takeshi
    Matoba, Shuichiro
    Kuroyanagi, Hiroya
    Takano, Toshimi
    CANCER SCIENCE, 2017, 108 (05) : 853 - 858
  • [37] Autophagy controls programmed death-ligand 1 expression on cancer cells (Review)
    Gao, Lijuan
    Chen, Yongshun
    BIOMEDICAL REPORTS, 2021, 15 (04)
  • [38] Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients
    Takamori, Shinkichi
    Takada, Kazuki
    Azuma, Koichi
    Jogo, Tomoko
    Shimokawa, Mototsugu
    Toyokawa, Gouji
    Hirai, Fumihiko
    Tagawa, Tetsuzo
    Kawahara, Akihiko
    Akiba, Jun
    Okamoto, Isamu
    Nakanishi, Yoichi
    Oda, Yoshinao
    Hoshino, Tomoaki
    Maehara, Yoshihiko
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (06) : 1916 - 1924
  • [39] Programmed Death Ligand 1 Expression as an Immunotherapy Biomarker for Patients with Lung Cancer
    Boyle, T. A.
    Yu, H.
    Ellison, K.
    Kowalewski, A. A.
    Rozeboom, L.
    Rivard, C.
    Chan, D.
    Hirsch, F. R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 825 - 825
  • [40] Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients
    Shinkichi Takamori
    Kazuki Takada
    Koichi Azuma
    Tomoko Jogo
    Mototsugu Shimokawa
    Gouji Toyokawa
    Fumihiko Hirai
    Tetsuzo Tagawa
    Akihiko Kawahara
    Jun Akiba
    Isamu Okamoto
    Yoichi Nakanishi
    Yoshinao Oda
    Tomoaki Hoshino
    Yoshihiko Maehara
    Annals of Surgical Oncology, 2019, 26 : 1916 - 1924
12345